{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T19:42:15Z","timestamp":1740166935402,"version":"3.37.3"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T00:00:00Z","timestamp":1550188800000},"content-version":"vor","delay-in-days":45,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["T32 \u2013HL076139"],"award-info":[{"award-number":["T32 \u2013HL076139"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine Case Reports"],"published-print":{"date-parts":[[2019]]},"DOI":"10.1016\/j.rmcr.2019.02.012","type":"journal-article","created":{"date-parts":[[2019,2,16]],"date-time":"2019-02-16T11:12:33Z","timestamp":1550315553000},"page":"304-306","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Respiratory dysfunction following initiation of mirabegron: A case report"],"prefix":"10.1016","volume":"26","author":[{"given":"Elizabeth S.","family":"Malsin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John M.","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa F.","family":"Wolfe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna P.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.rmcr.2019.02.012_bib1","doi-asserted-by":"crossref","first-page":"811","DOI":"10.4111\/kju.2010.51.12.811","article-title":"Beta3-adrenoceptor agonists: possible role in the treatment of overactive bladder","volume":"51","author":"Igawa","year":"2010","journal-title":"Kor. J. Urol."},{"issue":"1","key":"10.1016\/j.rmcr.2019.02.012_bib2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/apha.12010","article-title":"Autonomic nervous control of the urinary bladder","volume":"207","author":"Ochodnicky","year":"2013","journal-title":"Acta Physiol. (Oxf)."},{"issue":"2","key":"10.1016\/j.rmcr.2019.02.012_bib3","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1074\/mcp.M113.035600","article-title":"Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics","volume":"13","author":"Fagerberg","year":"2014","journal-title":"Mol. Cell. Proteomics"},{"issue":"12","key":"10.1016\/j.rmcr.2019.02.012_bib4","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/nbt1210-1248","article-title":"Towards a knowledge-based human protein Atlas","volume":"28","author":"Uhlen","year":"2010","journal-title":"Nat. Biotechnol."},{"issue":"10","key":"10.1016\/j.rmcr.2019.02.012_bib5","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/sj.ijo.0801039","article-title":"The tissue distribution of the human beta3-adrenoceptor studied using a monoclonal antibody: direct evidence of the beta3-adrenoceptor in human adipose tissue, atrium and skeletal muscle","volume":"23","author":"Chamberlain","year":"1999","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"issue":"8","key":"10.1016\/j.rmcr.2019.02.012_bib6","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1002\/pro.5560020802","article-title":"Structure, function, and regulation of adrenergic receptors","volume":"2","author":"Strosberg","year":"1993","journal-title":"Protein Sci."},{"issue":"2","key":"10.1016\/j.rmcr.2019.02.012_bib7","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000339271","article-title":"Beta-adrenergic receptors, from their discovery and characterization through their manipulation to beneficial clinical application","volume":"122","author":"Wachter","year":"2012","journal-title":"Cardiology"},{"issue":"1","key":"10.1016\/j.rmcr.2019.02.012_bib8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0014-2999(98)00021-1","article-title":"Cyclic AMP accumulation in rat soleus muscle: stimulation by \u03b22- but not \u03b23-adrenoceptors","volume":"348","author":"Roberts","year":"1998","journal-title":"Eur. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.rmcr.2019.02.012_bib9","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1172\/JCI2191","article-title":"The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle","volume":"102","author":"Gauthier","year":"1998","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.rmcr.2019.02.012_bib10","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0024-3205(92)90374-X","article-title":"Beta-adrenergic agonists and hypertrophy of skeletal muscles","volume":"50","author":"Kim","year":"1992","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.rmcr.2019.02.012_bib11","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1152\/physrev.00028.2007","article-title":"Role of beta-adrenoceptor signaling in skeletal muscle: implications for muscle wasting and disease","volume":"88","author":"Lynch","year":"2008","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.rmcr.2019.02.012_bib12","doi-asserted-by":"crossref","first-page":"160","DOI":"10.2527\/1998.761160x","article-title":"Overview of the effects of beta-adrenergic receptor agonists on animal growth including mechanisms of action","volume":"76","author":"Mersmann","year":"1998","journal-title":"J. Anim. Sci."},{"key":"10.1016\/j.rmcr.2019.02.012_bib13","doi-asserted-by":"crossref","first-page":"37504","DOI":"10.1038\/srep37504","article-title":"CL316,243, a beta3-adrenergic receptor agonist, induces muscle hypertrophy and increased strength","volume":"5","author":"Puzzo","year":"2016","journal-title":"Sci. Rep."},{"issue":"6 Pt 1","key":"10.1016\/j.rmcr.2019.02.012_bib14","first-page":"E726","article-title":"Slow to fast alterations in skeletal muscle fibers caused by clenbuterol, a beta 2-receptor agonist","volume":"254","author":"Zeman","year":"1988","journal-title":"Am. J. Physiol."},{"year":"2016","series-title":"Lioresal (Baclofen) Injection Package Insert","key":"10.1016\/j.rmcr.2019.02.012_bib15"},{"year":"2016","series-title":"Baclofen Tablet Package Insert","key":"10.1016\/j.rmcr.2019.02.012_bib16"},{"issue":"11","key":"10.1016\/j.rmcr.2019.02.012_bib17","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2165\/00002018-200427110-00004","article-title":"A benefit-risk assessment of baclofen in severe spinal spasticity","volume":"27","author":"Dario","year":"2004","journal-title":"Drug Saf."},{"issue":"5","key":"10.1016\/j.rmcr.2019.02.012_bib18","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.chest.2015.10.001","article-title":"Severe central sleep apnea associated with chronic baclofen therapy: a case series","volume":"149","author":"Olivier","year":"2016","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.rmcr.2019.02.012_bib19","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1177\/0883073813479668","article-title":"An unusual cause of flaccid paralysis and coma: baclofen overdose","volume":"29","author":"Caron","year":"2014","journal-title":"J. Child Neurol."},{"issue":"6","key":"10.1016\/j.rmcr.2019.02.012_bib20","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/EJA.0000000000000055","article-title":"Intrathecal baclofen toxicity: an unusual cause of paediatric postoperative coma and respiratory depression","volume":"31","author":"Stroud","year":"2014","journal-title":"Eur. J. Anaesthesiol."}],"container-title":["Respiratory Medicine Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007119300036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007119300036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T18:48:04Z","timestamp":1569264484000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213007119300036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":20,"alternative-id":["S2213007119300036"],"URL":"https:\/\/doi.org\/10.1016\/j.rmcr.2019.02.012","relation":{},"ISSN":["2213-0071"],"issn-type":[{"type":"print","value":"2213-0071"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Respiratory dysfunction following initiation of mirabegron: A case report","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmcr.2019.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}